Similar articles

• [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma].

  Wu HW, Liu TH. Wu HW, et al. Zhonghua Bing Li Xue Za Zhi. 2012 Nov;41(11):784-8. doi: 10.3760/cma.j.issn.0529-5807.2012.11.019. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 23302346 Review. Chinese. No abstract available.
• Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type.

  Clarke BA, Gilks CB. Clarke BA, et al. J Clin Pathol. 2010 May;63(5):410-5. doi: 10.1136/jcp.2009.071225. J Clin Pathol. 2010. PMID: 20418232 Review.
• Clinical significance of RCAS1 as a biomarker of uterine cancer.

  Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H. Sonoda K, et al. Gynecol Oncol. 2006 Dec;103(3):924-31. doi: 10.1016/j.ygyno.2006.05.047. Epub 2006 Jul 13. Gynecol Oncol. 2006. PMID: 16842844
• Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.

  Hoang LN, Han G, McConechy M, Lau S, Chow C, Gilks CB, Huntsman DG, Köbel M, Lee CH. Hoang LN, et al. Histopathology. 2014 Mar;64(4):585-96. doi: 10.1111/his.12286. Epub 2013 Dec 7. Histopathology. 2014. PMID: 24103020
• Immunohistochemical characterization of endometrial carcinomas: endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis.

  Yasuda M. Yasuda M. J Obstet Gynaecol Res. 2014 Dec;40(12):2167-76. doi: 10.1111/jog.12564. Epub 2014 Nov 3. J Obstet Gynaecol Res. 2014. PMID: 25363801 Review.